Maria Straßburger

Maria Straßburger is a researcher at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) in Jena, Germany, where she leads investigations within the Transfer Group Anti-infectives. Her work bridges fundamental fungal pathogenesis research and translational anti-infective development.

Her primary research focuses on Aspergillus fumigatus virulence mechanisms and host-pathogen interactions, with particular emphasis on:

• Phagosome manipulation strategies during infection
• Iron acquisition and oxidative stress response systems
• Molecular mechanisms of immunosuppressive mycotoxins
• Transcriptional regulation of virulence pathways
• Development of novel antimicrobial compounds

Analysis of her publication history reveals consistent contributions to high-impact journals, with recent work (2021-2023) increasingly focusing on the molecular interface between fungal pathogens and host cellular defenses. Her research demonstrates strong interdisciplinary integration of microbiology, immunology, and drug discovery.

Dr. Straßburger's research is supported by Leibniz-HKI's advanced infrastructure, including metabolomics platforms and the National Reference Center for Invasive Fungal Infections. She actively collaborates through the International Leibniz Research School, contributing to training next-generation scientists in medical mycology and anti-infective development.

The Transfer Group Anti-infectives operates at the cutting edge of fungal pathogenesis research, with recent discoveries (such as the 2023 Cell Host & Microbe paper on phagosome hijacking) revealing fundamental mechanisms with therapeutic potential. The group maintains strong connections to clinical mycology through institutional partnerships with Jena University Hospital.